What is Epitopea?
Founded in 2021 and based in Cambridge, United Kingdom, Epitopea is a dynamic medtech company dedicated to advancing cancer treatment methodologies. The company's focus on innovative therapeutic solutions aims to address critical unmet needs within the oncology sector. Epitopea's strategic positioning within the UK's thriving life sciences hub provides a fertile ground for research, development, and collaboration, enabling it to leverage cutting-edge scientific advancements for patient benefit.
How much funding has Epitopea raised?
Epitopea has raised a total of $31.6M across 2 funding rounds:
Other Financing Round
$650K
Other Financing Round
$31M
Other Financing Round (2022): $650K with participation from Defi Research Institute, Matters, and Smart-Chain
Other Financing Round (2024): $31M led by Advent Life Sciences, Cambridge Innovation Capital, and Investissement Quebec
Key Investors in Epitopea
Advent Life Sciences
Advent Life Sciences is a leading trans-Atlantic venture capital firm focused on building innovative life sciences businesses in the UK, Europe, and the USA. The firm specializes in early and mid-stage investments in companies that aim to develop first-in-class or best-in-class medicines and medical products across various modalities, including med tech and vaccines. With a hands-on approach, Advent Life Sciences partners closely with management teams to turn breakthrough science into approved therapies, achieving superior financial returns. Since its inception in 2006, the firm has successfully brought numerous innovative medicines and products to market.
Cambridge Innovation Capital
Cambridge Innovation Capital is a leading venture investor focused on supporting promising entrepreneurs in life sciences and deep tech within the Cambridge ecosystem. With a unique relationship with the University of Cambridge, they leverage their expertise and extensive network to identify and back innovative start-ups. The company provides financial backing and expert guidance to help these pioneers achieve their vision and create impactful, world-leading companies. Their commitment to sustainability and ESG principles aligns with their goal of enhancing financial returns while contributing to societal objectives.
Investissement Quebec
Founded in 1998 and headquartered in Montreal, Canada, Investissement Quebec is a company that intends to assist in the growth of investment in Quebec and contributing to economic development and job creation. The corporation offers businesses a full range of financial solutions such as loans, loan guarantees, and equity investments.
What's next for Epitopea?
The substantial enterprise-level backing Epitopea has received signals a pivotal stage of scaling and market penetration. This significant investment is expected to fuel further research and development, potentially accelerating clinical trials and expanding the company's therapeutic pipeline. Epitopea's strategic focus on cancer treatment, combined with this robust financial backing, suggests an aggressive trajectory towards bringing novel therapies to patients and solidifying its position as a key player in the medtech industry.
See full Epitopea company page
